EMEA-000744-PIP01-09

Key facts

Active substance
  • Amlodipine besylate
  • valsartan
  • hydrochlorothiazide
Therapeutic area
Cardiovascular diseases
Decision number
P/6/2010
PIP number
EMEA-000744-PIP01-09
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Ltd.

E-mail: paediatric.enquiries@novartis.com
Country: Switzerland
Phone: +41 61 324 1111
Fax: +41 61 324 8001

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating